17th - 18th April 2018 | Munich, Germany

Conference Day One

8:30 am - 10:00 am Morning Workshop: Ensuring Quality and the Right Corporate Cultural Requirements Across External Networks

With multiple challenges in ensuring quality and compliance across all global external networks, this workshop will look at what requirements and corporate behavioural frameworks are necessary to evaluate and understand the different aspects that allow the alignment of expectations between pharma and CMO.

Attend this Workshop to:

• Discuss the cultural aspects to be considered to hold integral partnerships
• Evaluate how to optimise management of companies across a global reach
• Understand the bigger picture for CMO selection, management and compliance

10:00 am - 10:05 am PharmaIQ Welcome

10:05 am - 10:10 am Chairman's Opening Address

Roger Cassidy - Managing Partner Tamesis Pharma
img

Roger Cassidy

Managing Partner
Tamesis Pharma

10:10 am - 10:25 am Icebreaker: What are Your Event Objectives?

To boost networking and interactivity, the conference will begin with an opportunity for everybody to get to know one another. Attendees will then have 15minutes to discuss their key objectives for attending the event. These will be used to influence discussions throughout the entire conference. At the end of the second day the objectives will be reviewed and there will be further opportunity to discuss any remaining points.

10:25 am - 11:10 am Case Study: Analysing the Challenges in Local External Manufacturing

Kyriakos Berberidis - Director Supply Chain and External Manufacturing Janssen
• Explore the challenges in managing local manufacturing sites
• Discuss what different strategies can be used to improve quality across production in emerging markets
• Understand what key steps should be taken to initiate better communication with external networks
img

Kyriakos Berberidis

Director Supply Chain and External Manufacturing
Janssen

• Evaluate how to create a stronger collaboration with external contract manufacturers
• Enhance manufacturing processes by producing a long term strategic partnership
• Ensure transparency and regulatory compliance between partners
img

Luiz Barberini

Operations Mng - External Manufacturing Latin America Head
Bayer

img

Nicolas Puljic

External Manufacturing Production Manager
Biogen

11:50 am - 12:10 pm Coffee Break


12:10 pm - 12:50 pm Supplier Footprint Management: How to Manage Complex and Large Scale External Supplier Footprints

Murat Kutu - Network Strategy Lead, External Supply Strategy Novartis
Yves Moinard - Head External Supply Operations Aseptics Novartis
• Establish a robust supply point decision process to control addition of new suppliers
• Develop a 3 tier supplier segmentation model to apply appropriate supplier oversight
• Identify strategic partners that align with your technology
img

Murat Kutu

Network Strategy Lead, External Supply Strategy
Novartis

img

Yves Moinard

Head External Supply Operations Aseptics
Novartis

12:50 pm - 1:30 pm How do we Define Strategic Partnerships?

Hans-Peter Grau - External Manufacturing Biologics Sanofi
• Discuss how to define strategic partnerships and when a partnership truly becomes strategic
• Hear how different relationship models can help structure optimal external partnerships
• Understand the different limitations and challenges faced with forming these partnerships
img

Hans-Peter Grau

External Manufacturing Biologics
Sanofi

1:30 pm - 2:30 pm Networking Lunch

2:30 pm - 3:10 pm What to Consider when Choosing your CMO Partner

Jan-Gunnar Gustafsson - Owner Bio Evaluation BO AB
• Discuss the different approaches that you need to take to choose the right CMO for you
• Establish the different considerations needed when working with either large or small molecules
• Understand the limitations and challenges in working with CMOs at early stages of your drug development
img

Jan-Gunnar Gustafsson

Owner
Bio Evaluation BO AB

3:10 pm - 3:50 pm Case Study: Forming Strategic Partnerships for Freeze Dried Products

Andrzej Hoczyk - Head of External Manufacturing Polpharma
- Discuss the different requirements and business models that were needed to choose the correct external partners
- Hear about product life cycle management through technology, cost and investment challenges
- Evaluate the need for stronger collaboration with CMOs
img

Andrzej Hoczyk

Head of External Manufacturing
Polpharma

img

Roger Cassidy

Managing Partner
Tamesis Pharma

Use this opportunity to discuss with peers key topics facing the industry. Led by expert facilitators, each roundtable discussion will last for 30 minutes with the opportunity to rotate to a second discussion point and share feedback at the end of the session

1. Optimising Communication Between Partners
Christophe Defrance, Outsourced Manufacturing Associate Director, UCB

2. How to Find a new External Partner
Kyriakos Berberidis, Director External Manufacturing and Supply, Janssen

3. How to Manage Communications with CMOs

4. How to Manage Challenges in Local Manufacturing Sites
Yves Moinard, Head External Supply Operations, Novartis
img

Christophe Defrance

Outsourced Manufacturing Associate Director
UCB

img

Kyriakos Berberidis

Director Supply Chain and External Manufacturing
Janssen

img

Olivier Wydhooge

Global Value Engineering and Technical Lead
Bayer

img

Yves Moinard

Head External Supply Operations Aseptics
Novartis

5:20 pm - 5:30 pm Chairman’s Summary of Day One

Roger Cassidy - Managing Partner Tamesis Pharma
img

Roger Cassidy

Managing Partner
Tamesis Pharma